Compare DexCom, Inc. (DXCM) vs Quanta Services Inc (PWR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Quanta Services Inc — how do they compare? DexCom, Inc. trades at $77.82 (market cap $28.06B), while Quanta Services Inc trades at $635.01 (market cap $97.37B). The key difference: Quanta Services Inc is far larger — about 3.5× DexCom, Inc.'s market cap, and Quanta Services Inc pays a 0.07% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.
| DXCM | PWR | |
|---|---|---|
Market Cap | $28.06B | $97.37B |
Sector | Health | Industrials |
52-Week High | $89.53 | $785.24 |
52-Week Low | $54.84 | $372.50 |
Enterprise Value | $27.03B | $103.32B |
Dividend Yield | — | 0.07% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DexCom (DXCM) trades at $74.12, down 2.92% on the day, with a bullish technical signal from moving averages. The company demonstrates strong fundamentals with consistent revenue growth, expanding profit margins, and a track record of beating earnings estimates. Recent regulatory approvals for its G7 15-day CGM in Canada and pediatric clearance for its Stelo OTC system in the U.S. highlight ongoing product expansion.
The investment thesis centers on DexCom's leadership in the growing CGM market, supported by strong financial execution and analyst optimism. Key risks include competition from Abbott, the commercial unproven nature of expansion into non-insulin Type 2 diabetes patients, and potential disruption from GLP-1 drug adoption. The consensus price target of $84.33 suggests ~14% upside from current levels.
Quanta Services (PWR) trades at $660.94, up 2.2% on the day, with a neutral technical signal and strong fundamental growth. Revenue has grown from $17.1B in 2022 to $28.5B in 2025, with net income reaching $1.03B. The stock carries a premium valuation with a P/E of 89, supported by a 75% analyst buy rating and a consensus price target of $836.80. Recent news highlights the company's positioning to benefit from AI-driven infrastructure spending and a record $48B backlog.
The outlook for PWR is positive, driven by robust infrastructure demand and strategic alignment with AI and grid modernization trends. Key risks include execution challenges from aggressive capital expenditure and sensitivity to economic cycles. The stock's premium valuation leaves little room for error, but strong earnings beats and institutional support suggest continued upside potential if growth targets are met.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Quanta Services Inc
Quanta Services is a leading provider of specialty contracting services, delivering comprehensive infrastructure solutions for the electric and gas utility, communications, pipeline, and energy industries in the United States, Canada, and Australia. Quanta reports its results under two reportable segments: electric power infrastructure solutions and underground utility and infrastructure solutions. In October 2021, the company completed the acquisition of Blattner, a provider of comprehensive engineering, procurement, and construction solutions to customers in the renewable energy industry.
Read more on PWR →
